Skip to main content

Considerations for Ensuring Safety and Efficacy of Vaccines and Therapeutic Proteins Manufactured by Using Platform Approaches Summary of a Workshop (2010) / Chapter Skim
Currently Skimming:

Appendix A Statement of Task
Pages 16-16

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 16...
... targeted at specific agents within a few months after agents are identified. The workshop will feature invited presentations and discussions on various topics addressing integrated platforms to produce safe and efficacious surrogate countermeasures in contexts that are expected to mimic those of future threat agents and that could shorten the regulatory approval process.
Read the entire page →

Key Terms

  • manufacturing platforms
  • therapeutic proteins
  • quality attributes
  • efficacious surrogate
  • approval process

  • feature invited
  • surrogate countermeasures
  • specific agents
  • countermeasure products
  • identified cqas

  • produce safe
  • addressing integrated
  • dod countermeasure
  • novel agents
  • critical quality

  • multiple platforms
  • regulatory approval
  • topics addressing
  • facilitating rapid
  • confer safety

  • integrated platforms
  • future threat
  • various topics
  • threat agents
  • efficacious vaccines

  • invited presentations
  • assuring production
  • rapid approval
  • readily lead
  • major component


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.